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ABSTRACT
Objective. Central line-associated bloodstream infections (CLABSIs) are a significant cause of morbidity in critically ill 
neonates and children. The objective of this study was to compare CLABSI rate associated with different types of central 
vascular catheters (CVCs) in a multidisciplinary neonatal and pediatric intensive care unit (ICU).
Methods. A prospective cohort study was conducted in a multidisciplinary neonatal and pediatric ICU. All patients, admitted 
between January 1st 2011 and February 29th 2012, requiring a CVC were included and monitored for CLABSI (defined by 
CDC/NHSN criteria). CLABSI rates were calculated for each type of CVC as CLABSI episodes/1000 catheter-days. CLABSI 
rates were compared between patients with single and multiple CVCs.
Results. Of the 557 patients admitted, 362 (65%) required insertion of a CVC (4259 patient-days, 3225 catheter-days, CVC uti-
lization ratio 0.76). There were 14 episodes of CLABSI. CLABSI rate was lowest for umbilical catheters (0/1000 catheter-days), 
followed by short-term noncuffed and nontunneled CVCs (3.1/1000 catheter-days) and peripherally inserted CVCs (8.8/1000 
catheter-days). Higher rates were observed with long-term cuffed and tunneled CVCs (15.9/1000 catheter days) and noncu-
ffed, nontunneled CVCs for temporary renal replacement therapy (RRT) (20.0/1000 catheter days). CLABSI rate expressed 
per 1000 catheter-days was 3.0 and 19.7 for patients with single or multiple CVCs at the same time, respectively. 
Conclusion. The use of noncuffed, nontunneled CVCs for temporary RRT and the presence of multiple CVCs at the same 
time are associated with a significant increase in the rate and risk of developing CLABSI in a multidisciplinary neonatal and 
pediatric ICU population.
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Introduction
During the last few decades, the deve-
lopment of new techniques to provide 
central vascular access has been a 
revolutionary step in the care of critically 
ill neonates and children. Unfortunately, 
the use of central vascular catheters 
(CVCs) is associated with the risk of 
central line-associated bloodstream 
infections (CLABSIs), caused by micro-
organisms that colonize the implanted 
device or contaminate the fluid path-
way. (1) CLABSIs are the single most 
important cause of health care-associ-
ated infections in neonatal (NICU) and 
pediatric intensive care units (PICU) 
(2-7) and are associated with increased 
morbidity,  hospital lenght of stay, and 
health care costs. (8) 
Several factors have been reported in 
critically ill neonates and children as 
being associated with an increased 
CLABSI rate, including the presence 
of multiple CVCs, (4) the total durati-
on of CVC use, (4,6) administration of 
parenteral nutrition, packed red blood 
cell transfusions, (5,6) and the use of 
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extracorporeal membrane oxygenation 
(ECMO). (4) Patient-related factors have 
also been reported to increase the risk 
for CLABSI, including age (neonates), 
birthweight, gastrointestinal diagnoses, 
oncologic diagnoses, and cardiac sur-
gery. (2,6,7,9)
The various types of CVCs are asso-
ciated with different risks of CLABSI 
in adults. (10) Although it is generally 
acknowledged that the same principle 
applies for pediatric population, the 
magnitude of variability in CLABSI rate 
with different types of CVCs in critically ill 
neonates and children is largely unkno-
wn. Recently, a study of CLABSI rates 
in all children under care in a children's 
hospital (intensive care, general wards, 
out-patient setting) identified the hig-
hest risk of CLABSI in neonates with 
peripherally inserted central venous 
catheters (PICCs) and the lowest risk 
in children with totally implanted CVCs 
(Porth-a-cath). (11) However, most of 
these patients were not critically ill. Pati-
ents being cared for in a multidisciplina-
ry neonatal and pediatric ICU probably 
have a different CLABSI risk profile. Few 
data exist regarding CLABSI rates with 
different types of CVCs in multidiscipli-
nary PICUs. (4) 
The goal of this study was therefore to 
prospectively assess the current bur-
den of CLABSI in our multidisciplinary 
neonatal and pediatric ICU and to iden-
tify the CLABSI rate associated with 
different types of CVCs. 
Materials and methods
This was a prospective study in a level 
III multidisciplinary 14-bed neonatal 
and pediatric PICU of Department of 
Paediatric Surgery and Intensive care 
at University Medical Center Ljubljana, 
Slovenia. It is a combined medical and 
surgical PICU that provides critical care 
for children from newborn through 18 
years old. The study was approved 
by the National Medical Ethics Com-
mittee. 
Participants for this study were all pati-
ents admitted to the PICU between 
January 1st 2011 and February 29th 
2012 who required a CVC. Patients 
were monitored for the development of 
CLABSI from the day of PICU admissi-
on until 48 hours after PICU discharge. 
Denominator data consisting of pati-
ent-days and central vascular catheter-
days (catheter days) were collected 
daily, at the same time each day, using 
standardized Center for Disease Con-
trol/National Healthcare Safety Network 
(CDC/NHSN) methods and definitions. 
(9) Data were separately collected 
and analyzed for the following CVC 
subgroups: 1. short-term noncuffed 
and nontunneled CVCs; 2. umbilical 
catheters (arterial and venous); 3. long-
term cuffed, tunneled CVCs; 4. noncu-
ffed, nontunneled CVCs for temporary 
renal replacement therapy (RRT) (RRT 
CVCs); and 5. peripherally inserted 
central venous catheters (PICCs). A 
subgroup of short-term noncuffed and 
nontunneled CVCs was used as a refe-
rence group for comparison of CLABSI 
risk between different types of CVCs. 
Patients with  2 CVCs in place at the 
same time were defined as having mul-
tiple CVCs. 
CLABSI was defined according to CDC/
NHSN surveillance definitions as labo-
ratory-confirmed bloodstream infection 
that is not secondary to an infection 
meeting CDC/NHSN criteria at another 
body site and a CVC was in place at the 
time of, or within 48 hours before, onset 
of the event (for additional information 
about these criteria refer to Horan et 
al. (12) According to the changed CDC 
CLABSI definition (beginning in January 
2008) 1 positive blood culture yielding a 
normal skin contaminant (eg, coagula-
se-negative staphylococci) did not fulfill 
the case definition and two or more 
positive blood cultures drawn on sepa-
rate occasions were required. (12)
Data-analysis. Descriptive analyses 
were performed to characterize the 
patient population, reporting mean/
median values with ranges and per-
centages. The CLABSI rate per 1000 
catheter-days was calculated separate-
ly for different types of CVCs by dividing 
the number of CLABSI by the number 
of catheter-days and multiplying the 
result by 1000. Chi-square test for equal 
proportions was used for bivariate com-
parisons of the risk and crude rates of 
CLABSI associated with the different 
types and numbers of CVCs. A p value 
of < 0.05 was considered statistically 
significant. SPSS for Windows (Ver-
sion 16.0; SPSS, Chicago, IL, USA) was 
used in the statistical analysis. 
Results
A total of 557 admissions to the PICU 
were identified during the 14-month 
study period from January 1st 2011 to 
February 29th 2012, of whom 258 were 
medical and 299 were surgical. A total 
of 362 admissions (65 %) involved the 
use of 1 or more CVCs. The mean age 
of the population was 2.7 years (range 
few hours – 18 years). A total of 457 
(82 %) admissions required mechani-
cal ventilation and 161 (29 %) required 
vasopressor/inotropic support. During 
the study period 26 (4.7 %) patients 
died, of whom 11 were medical and 15 
surgical patients. 
We identified a total of 4259 patient-
days, 3225 catheter-days (CVC utili-
zation ratio 0.76) and 14 episodes of 
CLABSI with an overall CLABSI rate of 
4.3/1000 catheter-days in our PICU. 
The use and duration of use for different 
types of CVCs is shown in table 1. The 
crude risk for development of CLAB-
SI, risk ratio for CLABSI and CLABSI 
rate per 1000 catheter-days by different 
types of CVCs are shown in table 2. We 
did not detect any episode of CLABSI 
associated with use of umbilical cathe-
ters. We used short-term noncuffed 
and nontunneled CVCs as a referen-
ce group for bivariate associations 
between the use of different types of 
CVCs and the risk of CLABSI. Patients 
that required RRT CVCs had 12.9-fold 
increased risk for developing CLABSI 
compared with the reference group of 
patients (p<0.001, Pearson’s chi-squa-
re test). Patients with long-term cuffed, 
tunneled CVCs and PICCs had 1.8- and 
1.9-fold increased risk, respectively, for 
developing CLABSI as compared with 
the reference group of patients, but 
this increased risk was not statistically 
significant.
We identified a total of 27 patients and 
254 catheter-days with multiple ( 2) 
CVCs in place at one time. Five of 14 
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children (35 %) with CLABSI had multi-
ple CVCs in place at the time of CLABSI. 
The use of multiple CVCs at the same 
time was associated with a crude risk 
for CLABSI of 18.5% and with a 5.7-fold 
increase in the risk of developing CLAB-
SI compared with the reference group 
of patients with only one CVC in place 
at one time (95% confidence interval 
(CI): 1.5-24.0). This increased risk 
was statistically significant (p<0.001, 
Pearson’s chi-square test). CLABSI rate 
expressed per 1000 catheter-days was 
19.7 and 3.0 in association with the use 
of multiple CVCs or single CVC at the 
same time, respectively. 
Discussion
In this study, CLABSI rate of 4.3 per 
1000 catheter-days was established in 
our multidisciplinary neonatal and pedi-
atric ICU. This overall CLABSI rate com-
pares favourably with some studies in 
PICUs that reported rates up to 20.6 per 
1000 catheter-days, (13-15) but is high-
er than the pooled mean rate of 3.0 per 
1000 catheter-days for medical/surgi-
cal PICUs reporting to the CDC/NHSN 
system. (9) The higher CLABSI rate in 
our study could be attributable to the 
large proportion of neonates, includ-
ing extremely premature neonates, in 
our PICU that are known to be at high-
est risk for CLABSI. (9) Furthermore, 
a high percentage of our patients are 
neonates and children undergoing 
complex cardiac surgery that are also 
known to have higher CLABSI rates, 
partly because of extensive use of inva-
sive devices. (9,16) Accordingly, in a 
multicenter study that included multi-
disciplinary as well as dedicated car-
diac PICUs, CLABSI rate was the same 
as in our study. (17) 
Short-term noncuffed and nontunneled 
CVCs are the most prevalent type of 
CVC used in our unit (70% of cathe-
ter-days) and therefore accounted for 
the majority of CLABSIs (50%) in our 
study. However, when CLABSI rate 
was expressed per 1000 catheter-days, 
short-term noncuffed and nontunneled 
CVCs had a CLABSI rate of 3.1, which 
was lower than the rate for long-term 
cuffed, tunneled CVCs, RRT CVCs and 
PICCs, but considerably higher than 
the CLABSI rate for umbilical catheters. 
We observed the highest CLABSI rate 
of 20.0 per 1000-catheter days in RRT 
CVCs. Patients that required RRT CVC 
had a 12.9-fold increased risk for deve-
loping CLABSI compared to patients 
with short-term noncuffed and nontun-
neled CVCs. Our results are consistent 
with the study by Odetola et al. that also 
observed an increased risk of develo-
ping CLABSI in PICU patients requiring 
RRT CVC. (4) The observed increase in 
CLABSI risk in neonates and children 
requiring RRT has a number of intuitive 
pathophysiologic explanations. First, 
these patients are exposed to immuno-
suppressive effects of extracorporeal 
circulation. The initial response is main-
ly proinflammatory, followed by an anti-
Table 1.  The use of different types of central vascular catheters (CVCs).
Type of central vascular catheter Number of patients Catheter days
Duration of catheter use in days,
median (range)
Short-term noncuffed and nontunneled 
CVCs
217 2248 5 (1-45)
Umbilical vascular catheters 75 524 4 (1-11)
Long-term cuffed and tunneled CVCs 46 189 12 (1-120)
Noncuffed, nontunneled CVCs for tempo-
rary renal replacement therapy
8 150 8 (1-32)
Peripherally inserted CVC 16 114 4 (1-55)
Table 2.  Crude risk for development of central line-associated bloodstream infection (CLABSI), risk ratio (RR) and 
CLABSI rate per 1000 catheter-days by different types of central vascular catheters (CVCs). 







CLABSI rate per 1000 
catheter days*
Short-term noncuffed and 
nontunneled CVCs
7 7/217 (3.2) reference group 3.1
Umbilical vascular catheters 0 0 NA 0.0
Long-term cuffed and tunneled CVCs 3 3/46 (6.5) 1.8 (0.7-4.8) 15.9
Noncuffed, nontunneled CVCs for 
temporary renal replacement therapy
3 3/8 (37.5) 12.9 (3.6-46.1)† 20.0
Peripherally inserted CVC 1 1/16 (6.3) 1.9 (0.6-6.6) 8.8
CI, confidence interval; NA, non-applicable; RR, risk ratio.
*Number of CLABSI/Number of catheter-days x 1000 
†p < 0.05 compared to short-term noncuffed and  nontunneled central venous catheters
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nflammatory response. (18) If the anti-
nflammatory response is pronounced 
or prolonged, the host becomes immu-
nosuppressed, susceptible to second-
ary infections (19) and less tolerant of 
microcontamination that an immune 
competent host could effectively miti-
gate. (7) Second, increased suscepti-
bility for CLABSI is exacerbated by the 
need to routinely access RRT CVCs for 
blood-sampling and treatment in these 
patients. (20) A greater number of CVC 
interruptions are known to predispose 
PICU patients to CLABSI. (21) Thirdly, 
neonates and children with RRT CVCs 
often have multiple other CVCs. The 
increased risk of CLABSI in this popu-
lation warrants further study to better 
understand the nature of this risk and 
to develop specific prevention interven-
tions. In adults with acute renal failure, 
noncuffed, nontunneled hemodialysis 
CVCs are associated with a substan-
tially higher risk of CLABSI compared 
to cuffed and tunneled hemodialysis 
CVCs, (10,22) so one intervention to 
reduce CLABSI rate in this high risk 
PICU population could be the use of 
short-term cuffed and tunneled RRT 
CVCs for temporary RRT.
In our study, long-term cuffed, tunneled 
CVCs were the subgroup of CVCs with 
the second highest CLABSI rate per 
1000 catheter-days (15.9) and were 
associated with a 1.8-fold increased 
risk of developing CLABSI as com-
pared with the short-term noncuffed 
and nontunneled CVCs. Similar to the 
study by Odetola et al., this increase 
did not reach statistical significance. 
(4) The high CLABSI rate in long-term 
cuffed, tunneled CVCs was unexpected 
as these CVCs are generaly associated 
with a low prevalence of CLABSI, a 
characteristic thought to be related to 
the use of a subcutaneous tunnel and 
cuff before entering the vein. (23) How-
ever, all patients with long-term cuffed, 
tunneled CVCs complicated by CLABSI 
in our study were high risk premature 
infants with surgical intestinal diseases 
and long-term need for total parenteral 
nutrition. Surgical neonates with long-
term tunneled CVCs were previously 
reported to have high CLABSI rates of 
24% (compared to 6.5% in our study). 
(24) Several other explanations exist for 
the high CLABSI rate in our population 
with long-term cuffed, tunneled CVCs. 
First, total parenteral nutrition, prematu-
rity and low birth-weight are recognized 
risk factors for CLABSI. (25,26) Second, 
patients with gastrointestinal diseases 
have an  increased risk for CLABSI. 
(7,27) Furthermore, bacterial transloca-
tion across the intestinal mucosa is also 
more frequent in patients with gastroin-
testinal diseases and may be attributed 
by default to a CVC when using the cur-
rent CDC/NHSN surveillance definition 
for CLABSI. (7) For long-term central 
venous access, cuffed and tunneled 
CVCs are associated with a higher risk 
for CLABSI than totally implanted devic-
es (Porth-a-cath). (10,11,28). However, 
if the patient needs continuous access 
for many days or intermittent access 
day after day, a cuffed and tunneled 
CVC is preferable to a totally implanted 
device. (10) According to this, switch-
ing to Porth-a-cath CVCs would not 
be appropriate for long-term central 
venous access in our population of 
neonates with complex surgical intesti-
nal diseases that currently receive long-
term cuffed, tunneled CVCs.
In our study PICCs, with a CLABSI rate 
of 8.8 per 1000 catheter-days, posed 
a 1.9-fold increased risk for CLABSI 
compared to short-term noncuffed and 
nontunneled CVCs. As PICCs are used 
exclusively in neonates in our unit, we 
looked at other studies of PICCs in 
critically ill neonates. The incidence of 
CLABSI in neonates with PICC lines 
ranges from 0 to 18.2 episodes per 
1000 catheter-days, with the higher 
rates occuring in neonates weighing 
less than 1500 g. (29-32) Njere et al. 
recently reported PICC CLABSI rate of 
18.2 per 1000 catheter-days in medical 
neonates and 15.8 per 1000-days in 
surgical neonates in NICU. (29) Com-
paring these results with data in chil-
dren outside ICU (PICC CLABSI rate 
of 2.58 per 1000 catheter-days), (33) 
emphasizes the fact that neonates and 
children in ICU have a different risk pro-
file for CLABSI compared to neonates 
and children on general wards. There-
fore, comparing studies of CLABSI from 
different settings is challenging and 
should be adjusted for different hospital 
locations, types of illness and degrees 
of illness severity.  
No CLABSI episode associated with the 
use of umbilical catheters was detected 
during the study period. Our results are 
better than the reported pooled mean 
umbilical catheter-associated CLABSI 
rate of 0.9-3.9 per 1000 catheter-days 
for level III NICUs in the USA. (9) Other 
than the type of catheter, a very impor-
tant extrinsic risk factor for CLABSI is 
duration of catheterization. (32,33) The 
median duration of umbilical catheter 
use in our study was 4 days (range 
1-11 days), which was less than for 
other types of CVCs and could be a 
very important factor in zero CLABSI 
rate. This is further emphasized by a 
recent randomized trial that evaluated 
whether long-term umbilical venous 
catheterization (up to 28 days) would 
result in the same or fewer CLABSIs 
when compared with neonates who 
were randomized to short-term umbili-
cal venous catheterization for 7-10 
days followed by PICCs. CLABSI rate 
was higher (20%) among long-term 
catheterized neonates when compared 
with short-term catheterized neonates 
(13%). (34) It is therefore very important 
to continually reassess the need for all 
types of CVCs and promptly remove 
unnecessary CVCs, particularly during 
the second week of catheterization and 
thereafter. (7) 
Our data confirm previous findings (3,6) 
that the presence of multiple CVCs at 
the same time is associated with an 
increased risk for CLABSI. In our study, 
the presence of multiple CVCs was asso-
ciated with a 5.7-fold increased risk for 
CLABSI compared with the presence of 
a single CVC. CLABSI occurred in 2.7% 
of children with a single and 18.5 % of 
children with multiple CVCs. CLABSI 
rate expressed per 1000 catheter-days 
was 3.0 and 19.7 in association with the 
use of a single CVC or multiple CVCs at 
the same time, respectively. 
Several limitations should be considered 
when interpreting our findings. First, 
this is a small cohort, single-institution 
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study and our findings may not be gen-
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we were underpowered to perform mul-
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CLABSI rates should be achieved with 
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